Rankings
▼
Calendar
BCYC Q3 2018 Earnings — Bicycle Therapeutics plc Revenue & Financial Results | Market Cap Arena
BCYC
Bicycle Therapeutics plc
$360M
Q3 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
Gross Profit
-$4M
-250.4% margin
Operating Income
-$6M
-394.8% margin
Net Income
-$8M
-477.8% margin
EPS (Diluted)
$-0.58
QoQ Revenue Growth
-3.1%
Cash Flow
Operating Cash Flow
-$5M
Free Cash Flow
-$5M
Stock-Based Comp.
$229,000
Balance Sheet
Total Assets
$62M
Total Liabilities
$8M
Stockholders' Equity
$29M
Cash & Equivalents
$48M
← FY 2018
All Quarters
Q4 2018 →